Furthermore, mice that received intravenous implantation of NLRP3‐deficient HCC cells exhibited significantly reduced tumor growth and lower rates of metastasis compared with mice implanted with normal HCC cells. The gene discussed is NLRP3; the disease is hepatocellular carcinoma.